The dynamic interaction between pain and opioid misuse

No abstract is available for this paper.

• Publication year

  2018

• Venue

  British Journal of Pharmacology

• Publication date

  2018-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bph.13873PMID 28602044PMCID PMC6016619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The dynamic interaction between pain and opioid misuse

  2018cited by this paper
• The endocannabinoid hydrolysis inhibitor SA‐57: Intrinsic antinociceptive effects, augmented morphine‐induced antinociception, and attenuated heroin seeking behavior in mice

  2017cited by this paper
• Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study

  2016cited by this paper
• Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.

  2016cited by this paper
• Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis.

  2016cited by this paper
• CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

  2016cited by this paper
• Structure-based discovery of opioid analgesics with reduced side effects

  2016cited by this paper
• Innovative Program Targets Five Common Pain Syndromes With Non-opioid Alternatives.

  2016cited by this paper
• The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study

  2016cited by this paper
• Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain.

  2016cited by this paper
• New approaches to treating pain.

  2016cited by this paper
• A randomized trial of a pain management intervention for adults receiving substance use disorder treatment.

  2016cited by this paper
• Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban Setting.

  2016cited by this paper
• Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids.

  2016cited by this paper
• Opioid and cannabinoid synergy in a mouse neuropathic pain model

  2016cited by this paper
• Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

  2016cited by this paper
• Primary Care Patients with Drug Use Report Chronic Pain and Self-Medicate with Alcohol and Other Drugs

  2016cited by this paper
• Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?

  2016cited by this paper
• Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication

  2016cited by this paper
• The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension‐induced visceral pain models in Rodents

  2015cited by this paper
• Mindfulness Meditation-Based Pain Relief Employs Different Neural Mechanisms Than Placebo and Sham Mindfulness Meditation-Induced Analgesia

  2015cited by this paper
• Microglia Disrupt Mesolimbic Reward Circuitry in Chronic Pain

  2015cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015cited by this paper
• Evidence of CNIH3 involvement in opioid dependence

  2015cited by this paper
• Prescription monitoring programs and emergency department visits involving opioids, 2004-2011.

  2015cited by this paper
• Text Messaging for Addiction: A Review

  2015cited by this paper
• Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis

  2015cited by this paper
• Drug-poisoning deaths involving heroin: United States, 2000-2013.

  2015cited by this paper
• Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors

  2015cited by this paper
• Smartphone and Mobile Application Utilization Prior to and Following Treatment Among Individuals Enrolled in Residential Substance Use Treatment.

  2015cited by this paper
• Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons

  2015influential reference
• Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system

  2015cited by this paper
• Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United States.

  2015cited by this paper
• Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1.

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors

  2015cited by this paper
• Packaging interventions to increase medication adherence: systematic review and meta-analysis

  2015cited by this paper
• Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum

  2015cited by this paper
• Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward.

  2015cited by this paper
• Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis.

  2015cited by this paper
• Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States.

  2015cited by this paper
• Prescription drug monitoring and drug overdose mortality

  2014cited by this paper
• Vital Signs: Variation Among States in Prescribing of Opioid Pain Relievers and Benzodiazepines — United States, 2012

  2014cited by this paper
• Disrupted Brain Circuitry for Pain‐Related Reward/Punishment in Fibromyalgia

  2014cited by this paper
• The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain.

  2014cited by this paper
• The Promises and Pitfalls of Digital Technology in Its Application to Alcohol Treatment

  2014cited by this paper
• Hippocampal Long-Term Potentiation Is Disrupted during Expression and Extinction But Is Restored after Reinstatement of Morphine Place Preference

  2014cited by this paper
• The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.

  2013cited by this paper
• Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism

  2013cited by this paper
• Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

  2013cited by this paper
• Opiate-Dependent Patients on a Waiting List for Methadone Maintenance Treatment Are at High Risk for Mortality Until Treatment Entry

  2013cited by this paper
• A blueprint of pain curriculum across prelicensure health sciences programs: one NIH Pain Consortium Center of Excellence in Pain Education (CoEPE) experience.

  2013cited by this paper
• An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.

  2013cited by this paper
• A Population Pharmacokinetic and Pharmacodynamic Study of a Peripheral κ-Opioid Receptor Agonist CR665 and Oxycodone

  2013cited by this paper
• Injectable, Cellular-Scale Optoelectronics with Applications for Wireless Optogenetics

  2013cited by this paper
• CDC Grand Rounds: Prescription Drug Overdoes - A U.S. Epidemic

  2012cited by this paper
• Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update

  2012cited by this paper
• CDC grand rounds

  2012cited by this paper
• Cerebral interactions of pain and reward and their relevance for chronic pain.

  2012cited by this paper
• CDC grand rounds: prescription drug overdoses - a U.S. epidemic.

  2012cited by this paper
• Distinguishing features of cancer patients who smoke: pain, symptom burden, and risk for opioid misuse.

  2012cited by this paper
• RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH

  2012cited by this paper
• Pain relief produces negative reinforcement through activation of mesolimbic reward–valuation circuitry

  2012cited by this paper
• Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours.

  2011cited by this paper
• Prescription drug monitoring programs and death rates from drug overdose.

  2011cited by this paper
• Improving temporal efficiency of outpatient buprenorphine induction.

  2011cited by this paper
• Nonmedical Prescription Opioid Use and Mental Health and Pain Comorbidities: A Narrative Review

  2011cited by this paper
• Cannabinoid–Opioid Interaction in Chronic Pain

  2011cited by this paper
• Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission.

  2010influential reference
• The prevalence of chronic pain in United States adults: results of an Internet-based survey.

  2010cited by this paper
• Internet‐based interventions for young people with problematic substance use: a systematic review

  2010cited by this paper
• Does Report of Craving Opioid Medication Predict Aberrant Drug Behavior Among Chronic Pain Patients?

  2009cited by this paper
• Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking

  2009cited by this paper
• Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain

  2009cited by this paper
• 2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?

  2009cited by this paper
• Reward processing by the opioid system in the brain.

  2009cited by this paper
• Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning

  2009cited by this paper
• Prescription Opioid Aberrant Behaviors: A Pilot Study of Sex Differences

  2009cited by this paper
• The Neurobiology of Addictive Disorders

  2009cited by this paper
• Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders.

  2008cited by this paper
• Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors.

  2008cited by this paper
• Predicting Opioid Misuse by Chronic Pain Patients: A Systematic Review and Literature Synthesis

  2008cited by this paper
• What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.

  2008cited by this paper
• Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.

  2007cited by this paper
• Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.

  2007cited by this paper
• Development and validation of the Current Opioid Misuse Measure

  2007cited by this paper
• Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction

  2007cited by this paper
• Behavioral Counseling Content for Optimizing the Use of Buprenorphine for Treatment of Opioid Dependence in Community-Based Settings: A Review of the Empirical Evidence

  2007cited by this paper
• Synergy between Δ9-tetrahydrocannabinol and morphine in the arthritic rat

  2007cited by this paper
• Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.

  2006cited by this paper
• Influence of psychotherapy attendance on buprenorphine treatment outcome.

  2005cited by this paper
• Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.

  2004cited by this paper
• Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration

  2003cited by this paper
• Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities.

  2003cited by this paper
• Opioid therapy for chronic pain.

  2003cited by this paper
• Management of drug and alcohol withdrawal.

  2003cited by this paper
• Successful Pain Management for the Recovering Addicted Patient.

  2002cited by this paper
• A 33-year follow-up of narcotics addicts.

  2001cited by this paper
• Screening for Problematic Prescription Opioid Use

  2001cited by this paper
• Changes in reward‐induced brain activation in opiate addicts

  2001cited by this paper
• Characteristics of methadone maintenance patients with chronic pain.

  2000cited by this paper

• POST-OPERATIVE PAIN CONTROL IN ARTHROSCOPIC ROTATOR CUFF REPAIRS: A PROSPECTIVE, DOUBLE-BLINDED, RANDOMISED CONTROLLED TRIAL COMPARING INTERSCALENE CATHETERS AND SINGLE SHOT BLOCKS

  2026cites this paper
• Contemporaneous Link Between Pain and Craving in Patients Recovering from Prescription Opioid Use Disorder During Residential Treatment

  2025cites this paper
• Effects of Oliceridine Versus Sufentanil on Hemodynamic Stability in Elderly Hypertensive Patients During Laryngeal Mask Airway Anesthesia: A Randomized Controlled Trial

  2025cites this paper
• Postpartum Persistent Opioid Use After Opioid Exposure for Childbirth.

  2025cites this paper
• The need to incorporate polysubstance use in neuropsychopharmacology research: Biological lessons and new opportunities

  2025cites this paper
• Selective neural inhibition via photobiomodulation alleviates behavioral hypersensitivity associated with small sensory fiber activation

  2024cites this paper
• Transdiagnostic factors predicting prescription opioid-use disorder severity: A 12-month prospective study in patients on long-term opioid therapy for chronic pain.

  2024cites this paper
• The relationship of pain intensity and opioid craving with delayed methadone dose: A preliminary study of individuals with opioid use disorder

  2024cites this paper
• A Randomized Comparison Between Interscalene and Combined Interscalene-Suprascapular Blocks for Arthroscopic Shoulder Surgery: A Prospective Clinical Study

  2024cites this paper
• Substance use disorders, physical health and recovery capital: Examining the experiences of clients and the alcohol and other drug workforce.

  2023cites this paper
• Toward a Psychological Model of Chemical Coping with Opioids in Cancer Care

  2023cites this paper
• The Covid 19 Pandemic Effect on the Epidemiology of Thoracolumbar Fractures Presenting to the Emergency Department in Patients Above 65 years Old

  2022cites this paper
• Operant Self-medication for Assessment of Spontaneous Pain Relief and Drug Abuse Liability in Mouse Models of Chronic Pain.

  2022cites this paper
• High-CBD Cannabis Vapor Attenuates Opioid Reward and Partially Modulates Nociception in Female Rats

  2022cites this paper
• Impact Of the Covid-19 Pandemic on The Prevalence of Thoracolumbar Vertebral Compression Fractures in Elderly People

  2022cites this paper
• Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse.

  2021cites this paper
• Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France

  2021cites this paper
• The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders

  2021cites this paper
• Kyphoplasty for Elderly Patients With Vertebral Compression Fractures—Do We Save Lives? Mortality Rates Analysis Comparison in a Long-Term Follow-Up Cohort

  2021cites this paper
• Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias.

  2021cites this paper
• Mice with High FGF21 Serum Levels Had a Reduced Preference for Morphine and an Attenuated Development of Acute Antinociceptive Tolerance and Physical Dependence

  2021cites this paper
• Expanding access to nurse-managed medication for opioid use disorder.

  2021cites this paper
• Telemedicine and current clinical practice trends in the COVID-19 pandemic

  2020cites this paper
• Emerging Trends in Pediatric Opioid Prescribing Practices

  2020cites this paper
• Is Buprenorphine Effective for Chronic Pain? A Systematic Review and Meta-analysis.

  2020cites this paper
• Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ Opioid Receptor.

  2020cites this paper
• CE: Opioid Use Disorder: Pathophysiology, Assessment, and Effective Interventions.

  2020cites this paper
• Development and validation of the Capacity to Treat Chronic Pain and Opioid Use Disorder (CAP-POD) questionnaire

  2020cites this paper
• Pain Anxiety as a Mechanism Linking Pain Severity and Opioid Misuse and Disability Among Individuals With Chronic Pain.

  2019cites this paper
• Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

  2019cites this paper
• Does Rebound Pain after Peripheral Nerve Block for Orthopedic Surgery Impact Postoperative Analgesia and Opioid Consumption? A Narrative Review

  2019cites this paper
• Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review

  2019cites this paper
• Interactions between pain states and opioid reward assessed with intracranial self-stimulation in rats.

  2019cites this paper
• How Have Chronic Pain Management Programs Progressed? A Mapping Review

  2019cites this paper
• Repeated Morphine Produces Sensitization to Reward and Tolerance to Antiallodynia in Male and Female Rats with Chemotherapy-Induced Neuropathy

  2018cites this paper
• Comorbid opioid dependence and chronic pain : clinical implications

  2018cites this paper
• The dynamic interaction between pain and opioid misuse

  2018cites this paper
• A Review of the Opioid Epidemic: What Do We Do About It?

  2018influential citation
• Management of Challenging Pharmacologic Issues in Chronic Pain and Substance Abuse Disorders.

  2018cites this paper
• Undertreated or overtreated? Opioids for postdelivery analgesia.

  2018cites this paper
• Emerging areas of opioid pharmacology

  2018cites this paper
• Analysis of predictors of opioid-free analgesia for management of acute post-surgical pain in the United States

  2018cites this paper
• Current and emerging options to combat the opioid epidemic.

  2018cites this paper
• Patients With Major Depressive Disorder Experience Increased Perception of Pain and Opioid Consumption Following Total Joint Arthroplasty.

  2017cites this paper
• Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials?

  2017cites this paper